Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2002
11/28/2002WO2002078641A3 Pyrrolidine sulfonamides
11/28/2002WO2002062777A3 Amino ceramide-like compounds and therapeutic methods of use
11/28/2002WO2002050069A3 Sulfonylpyrroles for controlling microorganisms
11/28/2002US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders
11/28/2002US20020177609 Fatty alcohol drug conjugates
11/28/2002US20020177594 Inhibitors of histone deacetylase
11/28/2002DE10124867A1 New substituted (hetero)aryl-alkenes or -alkynes, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates
11/28/2002CA2447671A1 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/27/2002EP1259483A1 METHOD FOR PRODUCING $g(b)-ALANINAMIDES
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002EP0931064B1 Stabilised monomer composition
11/27/2002EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/27/2002CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1381445A Multi-substitutent beta-monofluoropyrrole compounds and preparing process thereof
11/27/2002CN1094931C Antithrombotic organic nitrates
11/27/2002CN1094926C Antimer pure acetacetates, its preparation method and use
11/26/2002US6486343 Substituted phenyl keto enols as pesticides and herbicides
11/26/2002US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002US6486180 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2002US6486178 Indane derivatives
11/26/2002US6486165 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/26/2002CA2055174C Process for the synthesis of alpha-((dialkylamino) substituted-methylene)-beta-oxo-(substituted) propanenitriles
11/22/2002WO2003101942A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action
11/22/2002CA2445571A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
11/21/2002WO2002092601A1 Refined routes to chlorin building blocks
11/21/2002WO2002070654A3 Peptide deformylase inhibitors
11/21/2002WO2002046152A3 Coniosetin and derivatives thereof, method for producing the same and use thereof
11/21/2002WO2002042271A3 Biphenylcarboxamides useful as lipid lowering agents
11/21/2002US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002US20020173536 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
11/21/2002US20020173530 Single morphic forms of metalloproteinase inhibitors
11/21/2002US20020173529 Fungicide active substance combinations
11/21/2002US20020173508 Enzyme inhibitors; antiinflammatory agents, antiarthritic agents
11/21/2002US20020173500 Hypotensive agents; antiischemic agents
11/21/2002US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020170124 Primary intermediates for oxidative coloration of hair
11/20/2002EP1258476A1 Alpha-amino acid derivatives, method for their preparation and their use as dipeptidyl-peptidase IV inhibitors (DPP IV)
11/20/2002EP1258250A1 Nerve protective drugs
11/20/2002EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002EP1257534A1 Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester
11/20/2002EP1257360A1 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions
11/20/2002EP1257172A2 Fungicidal agents containing pyrrolidones as their active agents and use thereof for treating plants
11/20/2002EP1147101B1 Reverse hydroxamate inhibitors of matrix metalloproteinases
11/20/2002EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002EP0917465B1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing the same agents
11/20/2002CN1380286A Levo-1-ethyl-2-aminomethylpentazane and its preparation method
11/20/2002CN1094488C Polymerizable urea/ureido functional monomers
11/20/2002CN1094486C Benzal compound and preparation method
11/20/2002CN1094485C Process for preparing N-pyrrolidone acetate
11/19/2002US6482974 From tri-o-acetyl-d-erythro-4-pentulosonic acid esters
11/19/2002US6482973 From tri-o-acetyl-d-erythro-4-pentulosonic acid esters
11/19/2002US6482949 Colormetric sensor compositions and methods
11/19/2002US6482943 Quinones as disease therapies
11/19/2002US6482920 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/19/2002US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002CA2155931C Inhibitors of thrombosis
11/19/2002CA2115143C Macromonomers having reactive end groups
11/14/2002WO2002090366A1 Olefin polymerization catalysts containing a pyrrole bisimine ligand
11/14/2002WO2002090353A1 Sulfonamides
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002WO2002090314A1 Pyruvate derivatives
11/14/2002WO2002090310A1 Method for purifying a raw melt of at least one monomer by crystallization
11/14/2002WO2002090299A2 Method for the production of a purified melt of at least one monomer
11/14/2002WO2002089803A1 Composition for iontophoresis
11/14/2002WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002US20020169318 Novel thrombin inhibitors
11/14/2002US20020169296 Nucleotide sequences coding binding protein for use as markers in diagnosis and forensic evaluation in animal husbandry
11/14/2002US20020169202 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
11/14/2002US20020169197 Diaryl-enynes
11/14/2002US20020169196 Cyclic AMP-specific phosphodiesterase inhibitors
11/14/2002US20020169113 Orally available peptidic thrombin inhibitors
11/14/2002US20020169098 Cleaning composition
11/14/2002US20020168244 Locking nut, bolt and clip systems and assemblies
11/14/2002US20020166181 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
11/14/2002DE10120456A1 Polymergebundener Katalysator für die enantioselektive Aldol-/Mannichreaktion Polymer-bound catalyst for the enantioselective aldol / Mannich reaction
11/14/2002CA2447073A1 Olefin polymerization catalysts containing a pyrrole bisimine ligand
11/14/2002CA2446365A1 Sulfonamides
11/13/2002EP1256573A1 Process for producing stereoisomer of pyrrolidine derivative
11/13/2002EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes
11/13/2002EP1255753A2 Prodigiosin-derivatives as neoplastic and anti-viral agents
11/13/2002EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002EP1255733A1 Farnesyl transferase inhibitors
11/13/2002EP0920413B1 Boronic compound complexing reagents and complexes
11/13/2002EP0699074B1 Thrombin inhibitors
11/13/2002CN1379760A Process for preparation of amorphous atorvastatin calcium